We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1976
Apple Hospitality REIT
APLE
$3.85B
| $1.42K | ﹤0.01% |
122
-70
| -36% | -$821 |
2022 Q1
13 quarters
|
|
1977
DELISTED
NCS Multistage Holdings
NCSM
| $1.42K | ﹤0.01% |
48
| – | – |
2024 Q3
3 quarters
|
|
1978
Kolibri Global Energy
KGEI
$232M
| $1.36K | ﹤0.01% |
+198
| New | +$1.36K |
2025 Q2
0 quarters
|
|
1979
Costamare Bulkers Holdings
CMDB
$505M
| $1.34K | ﹤0.01% |
+155
| New | +$1.54K |
2025 Q2
0 quarters
|
|
1980
US Gold Corp
USAU
$228M
| $1.3K | ﹤0.01% |
107
| – | – |
2025 Q1
1 quarter
|
|
1981
Citi Trends
CTRN
$430M
| $1.3K | ﹤0.01% |
+39
| New | +$993 |
2025 Q2
0 quarters
|
|
1982
Rigel Pharmaceuticals
RIGL
$917M
| $1.29K | ﹤0.01% |
+69
| New | +$1.31K |
2025 Q2
0 quarters
|
|
1983
Aclaris Therapeutics
ACRS
$564M
| $1.28K | ﹤0.01% |
902
-2,040
| -69% | -$2.76K |
2023 Q4
6 quarters
|
|
1984
DELISTED
TrueCar
TRUE
| $1.28K | ﹤0.01% |
672
+378
| +129% | +$577 |
2025 Q1
1 quarter
|
|
1985
MainStreet Bancshares
MNSB
$175M
| $1.27K | ﹤0.01% |
+67
| New | +$1.22K |
2025 Q2
0 quarters
|
|
1986
American Superconductor
AMSC
$1.48B
| $1.25K | ﹤0.01% |
+34
| New | +$836 |
2025 Q2
0 quarters
|
|
1987
RF Industries
RFIL
$90.1M
| $1.24K | ﹤0.01% |
192
| – | – |
2025 Q1
1 quarter
|
|
1988
Seneca Foods Class A
SENEA
$1.21B
| $1.22K | ﹤0.01% |
+12
| New | +$1.08K |
2025 Q2
0 quarters
|
|
1989
USA Today Co
TDAY
$1B
| $1.21K | ﹤0.01% |
339
-9,890
| -97% | -$33.1K |
2021 Q1
17 quarters
|
|
1990
Anavex Life Sciences
AVXL
$138M
| $1.2K | ﹤0.01% |
+130
| New | +$1.11K |
2025 Q2
0 quarters
|
|
1991
TELA Bio
TELA
$50.1M
| $1.19K | ﹤0.01% |
613
+50
| +9% | +$65 |
2025 Q1
1 quarter
|
|
1992
DELISTED
FiscalNote
NOTE
| $1.12K | ﹤0.01% |
174
| – | – |
2024 Q3
3 quarters
|
|
1993
DELISTED
RAPT Therapeutics
RAPT
| $1.09K | ﹤0.01% |
136
-25,036
| -99% | -$191K |
2024 Q1
5 quarters
|
|
1994
DELISTED
SpartanNash
SPTN
| $1.09K | ﹤0.01% |
41
-15
| -27% | -$300 |
2014 Q4
42 quarters
|
|
1995
USCB Financial Holdings
USCB
$407M
| $1.04K | ﹤0.01% |
63
-37
| -37% | -$622 |
2024 Q4
2 quarters
|
|
1996
D-Wave Quantum Inc
QBTS
$5.53B
| $1.04K | ﹤0.01% |
71
-301
| -81% | -$3.54K |
2025 Q1
1 quarter
|
|
1997
Urban One Class D
UONEK
$18.1M
| $1.03K | ﹤0.01% |
163
| – | – |
2024 Q3
3 quarters
|
|
1998
Freightos
CRGO
$43.8M
| $1.02K | ﹤0.01% |
421
-78
| -16% | -$173 |
2025 Q1
1 quarter
|
|
1999
Baxter International
BAX
$12.6B
| $999 | ﹤0.01% |
33
-2,244
| -99% | -$68K |
2013 Q2
48 quarters
|
|
2000
Voyager Therapeutics
VYGR
$151M
| $986 | ﹤0.01% |
+317
| New | +$1.02K |
2025 Q2
0 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.